1
|
Horeman-Franse T, Postema RR, Fischer T, Calleja-Agius J, Camenzuli C, Alvino L, Hardon SF, Bonjer HJ. The relevance of reducing Veress needle overshooting. Sci Rep 2023; 13:17471. [PMID: 37838824 PMCID: PMC10576755 DOI: 10.1038/s41598-023-44890-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 10/13/2023] [Indexed: 10/16/2023] Open
Abstract
Safe insertion of the Veress needle during laparoscopy relies on the surgeons' technical skills in order to stop needle insertion just in time to prevent overshooting in the underlying organs. To reduce this risk, a wide variety of Veress needle systems were developed with safety mechanisms that limit the insertion speed, insertion depth or decouple the driving force generated by the surgeon's hand on the needle. The aim of this study is to evaluate current surgeons' perceptions related to the use of Veress needles and to investigate the relevance of preventing overshooting of Veress needles among members of the European Association of Endoscopic Surgery (EAES). An online survey was distributed by the EAES Executive Office to all active members. The survey consisted of demographic data and 14 questions regarding the use of the Veress needle, the training conducted prior to usage, and the need for any improvement. A total of 365 members residing in 58 different countries responded the survey. Of the responding surgeons, 36% prefer the open method for patients with normal body mass index (BMI), and 22% for patients with high BMI. Of the surgeons using Veress needle, 68% indicated that the reduction of overshoot is beneficial in normal BMI patients, whereas 78% indicated that this is beneficial in high BMI patients. On average, the members using the Veress needle had used it for 1448 (SD 3031) times and felt comfortable on using it after 22,9 (SD 78,9) times. The average years of experience was 17,6 (SD 11,1) and the surgeons think that a maximum overshoot of 9.4 (SD 5.5) mm is acceptable before they can safely use the Veress needle. This survey indicates that despite the risks, Veress needles are still being used by the majority of the laparoscopic surgeons who responded. In addition, the surgeons responded that they were interested in using a Veress needle with an extra safety mechanism if it limits the risk of overshooting into the underlying structures.
Collapse
Affiliation(s)
- T Horeman-Franse
- Department of Biomechanical Engineering, Delft University of Technology, TU-Delft, Mekelweg 2, 2628CD, Delft, The Netherlands.
- European Association of Endoscopic Surgery, Eindhoven, The Netherlands.
| | - R R Postema
- Department of Biomechanical Engineering, Delft University of Technology, TU-Delft, Mekelweg 2, 2628CD, Delft, The Netherlands
- Department of Surgery, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands
| | - T Fischer
- Department of Biomechanical Engineering, Delft University of Technology, TU-Delft, Mekelweg 2, 2628CD, Delft, The Netherlands
| | - J Calleja-Agius
- Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
| | - C Camenzuli
- Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
| | - L Alvino
- Neyenrode Business School, Amsterdam, The Netherlands
| | - S F Hardon
- Department of Biomechanical Engineering, Delft University of Technology, TU-Delft, Mekelweg 2, 2628CD, Delft, The Netherlands
- Department of Surgery, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands
| | - H J Bonjer
- Department of Surgery, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands
- European Association of Endoscopic Surgery, Eindhoven, The Netherlands
| |
Collapse
|
2
|
Haehl E, Alvino L, Rühle A, Sprave T, Grosu A, Nicolay N. PO-0966 Sarcopenia as prognostic marker in elderly HNSCC patients undergoing (chemo-)radiation. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07417-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|